Why the study?
Does PDE1C deficiency or inhibition prevent pathological cardiac remodeling and dysfunction in preclinical models?
Does PDE1C deficiency or inhibition prevent pathological cardiac remodeling and dysfunction in preclinical models?
PDE1C deficiency protects against pathological cardiac remodeling and dysfunction in mice, highlighting PDE1C as a potential therapeutic target for heart failure.
Answers are grounded in this paper and cite their sources.
PDE1C inhibition may attenuate remodeling in pressure overload; leaves open translation to human HF.
Cyclic nucleotide phosphodiesterase 1C (PDE1C) represents a major phosphodiesterase activity in human myocardium, but its function in the heart remains unknown. Using genetic and pharmacological approaches, we studied the expression, regulation, function, and underlying mechanisms of PDE1C in the pathogenesis of cardiac remodeling and dysfunction. PDE1C expression is up-regulated in mouse and human failing hearts and is highly expressed in cardiac myocytes but not in fibroblasts. In adult mouse cardiac myocytes, PDE1C deficiency or inhibition attenuated myocyte death and apoptosis, which was largely dependent on cyclic AMP/PKA and PI3K/AKT signaling. PDE1C deficiency also attenuated cardiac myocyte hypertrophy in a PKA-dependent manner. Conditioned medium taken from PDE1C-deficient cardiac myocytes attenuated TGF-β-stimulated cardiac fibroblast activation through a mechanism involving the crosstalk between cardiac myocytes and fibroblasts. In vivo, cardiac remodeling and dysfunction induced by transverse aortic constriction, including myocardial hypertrophy, apoptosis, cardiac fibrosis, and loss of contractile function, were significantly attenuated in PDE1C-knockout mice relative to wild-type mice. These results indicate that PDE1C activation plays a causative role in pathological cardiac remodeling and dysfunction. Given the continued development of highly specific PDE1 inhibitors and the high expression level of PDE1C in the human heart, our findings could have considerable therapeutic significance.
No takes yet. Share an insight, caveat, or question.
Knight et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: